Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 12, 2017
Headquarters: Boca Raton, FL
This filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) to the public. The presentation is intended for use in meetings with investors and analysts on or after September 12, 2017.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of an investor presentation rather than a financial statement containing quantitative data.
Material Changes
No material changes to financial performance or operations are detailed within the text of this Form 8-K. The filing solely announces the distribution of an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated September 2017. The content of this presentation may be modified during subsequent meetings with investors or analysts.
Legal Status of Information: The information in this report and the attached exhibit is furnished pursuant to Item 7.01. It is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. Furthermore, the information will not be incorporated by reference into any other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated September 2017) for actual financial data and strategic outlook.
- Verify if the presentation has been modified in subsequent investor meetings as noted in the filing.
- Confirm that the information in the presentation is not automatically incorporated by reference into other SEC filings.